| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,083,085 | |||
| Accounts receivable | 1,490,931 | |||
| Inventory | 3,338,404 | |||
| Prepaid expenses and other current assets | 4,476,549 | |||
| Total current assets | 17,388,969 | |||
| Operating lease right-of-use assets, net | 225,508 | |||
| Equity method investment | 552,183 | |||
| Other assets | 417,523 | |||
| Total assets | 18,584,183 | |||
| Current portion of unsecured convertible promissory note | 29,947,000 | |||
| Current portion of operating lease liabilities | 58,897 | |||
| Accounts payable | 10,192,388 | |||
| Accrued expenses | 5,314,320 | |||
| Income taxes payable | 302,000 | |||
| Total current liabilities | 45,814,605 | |||
| Operating lease liabilities | 188,801 | |||
| Warrant liability | 4,768,438 | |||
| Total liabilities | 50,771,844 | |||
| Common stock, par value 0.01 per share 260,000,000 shares authorized 53,887,233 and 23,905,635 shares issued and outstanding at september 30, 2025 and september 30, 2024, respectively | 538,873 | |||
| Additional paid-in capital | 572,983,229 | |||
| Accumulated deficit | -605,709,763 | |||
| Total stockholders' deficit | -32,187,661 | |||
| Total liabilities and stockholders' deficit | 18,584,183 | |||
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK)